Zions Bancorporation’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-21
Closed -$1.83K 929
2024
Q1
$1.83K Hold
21
﹤0.01% 838
2023
Q4
$2.03K Hold
21
﹤0.01% 822
2023
Q3
$1.86K Hold
21
﹤0.01% 816
2023
Q2
$1.82K Sell
21
-4
-16% -$347 ﹤0.01% 825
2023
Q1
$2.43K Hold
25
﹤0.01% 803
2022
Q4
$2.59K Sell
25
-86
-77% -$8.9K ﹤0.01% 931
2022
Q3
$9K Buy
111
+86
+344% +$6.97K ﹤0.01% 676
2022
Q2
$2K Sell
25
-5,005
-100% -$400K ﹤0.01% 962
2022
Q1
$388K Sell
5,030
-1,254
-20% -$96.7K 0.03% 268
2021
Q4
$555K Buy
6,284
+662
+12% +$58.5K 0.05% 214
2021
Q3
$435K Buy
5,622
+836
+17% +$64.7K 0.04% 215
2021
Q2
$399K Buy
4,786
+552
+13% +$46K 0.04% 206
2021
Q1
$320K Buy
4,234
+691
+20% +$52.2K 0.04% 214
2020
Q4
$311K Sell
3,543
-38
-1% -$3.34K 0.04% 194
2020
Q3
$272K Sell
3,581
-2,536
-41% -$193K 0.04% 176
2020
Q2
$754K Buy
6,117
+563
+10% +$69.4K 0.11% 82
2020
Q1
$469K Buy
5,554
+3,709
+201% +$313K 0.08% 95
2019
Q4
$156K Sell
1,845
-244
-12% -$20.6K 0.02% 266
2019
Q3
$141K Buy
2,089
+90
+5% +$6.08K 0.02% 293
2019
Q2
$171K Buy
1,999
+764
+62% +$65.4K 0.03% 248
2019
Q1
$110K Buy
1,235
+40
+3% +$3.56K 0.02% 296
2018
Q4
$102K Buy
1,195
+1,039
+666% +$88.7K 0.07% 125
2018
Q3
$15K Buy
156
+15
+11% +$1.44K ﹤0.01% 523
2018
Q2
$13K Buy
141
+15
+12% +$1.38K 0.01% 313
2018
Q1
$10K Sell
126
-826
-87% -$65.6K ﹤0.01% 407
2017
Q4
$85K Buy
952
+34
+4% +$3.04K 0.01% 258
2017
Q3
$85K Buy
918
+878
+2,195% +$81.3K 0.01% 459
2017
Q2
$4K Sell
40
-53
-57% -$5.3K ﹤0.01% 462
2017
Q1
$7K Buy
93
+1
+1% +$75 ﹤0.01% 434
2016
Q4
$8K Buy
92
+35
+61% +$3.04K ﹤0.01% 546
2016
Q3
$5K Hold
57
﹤0.01% 591
2016
Q2
$5K Hold
57
﹤0.01% 562
2016
Q1
$5K Buy
57
+29
+104% +$2.54K ﹤0.01% 631
2015
Q4
$2K Hold
28
﹤0.01% 703
2015
Q3
$3K Buy
+28
New +$3K ﹤0.01% 673
2015
Q2
Sell
-28
Closed -$3K 318
2015
Q1
$3K Buy
+28
New +$3K ﹤0.01% 714